Ismail Industries Limited operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ismail Industries Limited with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 43.09 billion Indian Rupees [US$643.72 million]
of which 100%
Nakamuraya Co., Ltd.
(41.37 billion Japanese Yen [US$399.20 million]
of which 70%
was Confectionery Business), and
Imuraya Group Company Limited
based in Japan
(38.64 billion Japanese Yen [US$372.92 million]
of which 88%
was Distribution Business).
Ismail Industries Limited reported sales of 17.01 billion Pakistan Rupees (US$162.26 million)
June of 2016.
increase of 38.9%
versus 2015, when the company's sales were 12.24 billion Pakistan Rupees.
Sales at Ismail Industries Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 120%).